Literature DB >> 25610137

The relationships of serum prealbumin levels with parameters that indicate severity of disease and emphysema pattern in patients with stable chronic obstructive pulmonary disease.

Hayrettin Gocmen1, Dane Ediger1, Esra Uzaslan1, Selim Doganay2, Nevin Ay Guney1, Ercument Ege1.   

Abstract

OBJECTIVE: Malnutrition, which is a complication frequently observed in chronic obstructive pulmonary disease (COPD) and negatively affects prognosis, has become a parameter that must be monitored. Even though various methods are applied to assess malnutrition, biochemical parameters, especially serum prealbumin levels, are useful.
MATERIALS AND METHODS: The relationships between serum prealbumin levels, which we used as an indicator of malnutrition, with the severity of disease and the parameters predicting emphysema in stable COPD patients with no additional health problems were determined in this prospective study.
RESULTS: One hundred stable COPD patients were evaluated prospectively. Serum prealbumin levels had a negative correlation with the total number of hospitalizations due to acute exacerbation, total hospitalization time, and average number of annual hospitalizations, whereas it showed a positive correlation with FEV1 and FEV1/FVC% values. Serum prealbumin levels were positively correlated with the length of the line connecting the costophrenic sinus to the dome of the diaphragm, which is used to assess the presence of emphysema and was negatively correlated with retrosternal distance. Also, in COPD patients with low prealbumin levels, while the FEV1 and FEV1/FVC% values and the length of the line connecting the costophrenic sinus to the diaphragm dome significantly decreased, the retrosternal distance dramatically increased compared to COPD patients with normal prealbumin levels.
CONCLUSION: Serum prealbumin levels were convenient for monitoring malnutrition in COPD, were correlated with spirometric and anamnestic data indicating the severity of COPD, and were useful in distinguishing the subtype of COPD due to its decrease in the presence of emphysema.

Entities:  

Keywords:  COPD; Emphysema; Malnutrition; Serum prealbumin level

Year:  2010        PMID: 25610137      PMCID: PMC4261256          DOI: 10.5152/eajm.2010.31

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  18 in total

1.  Variability in densitometric assessment of pulmonary emphysema with computed tomography.

Authors:  M Els Bakker; Jan Stolk; Hein Putter; Saher B Shaker; David G Parr; Eeva Piitulainen; Erich W Russi; Asger Dirksen; Robert A Stockley; Johan H C Reiber; Berend C Stoel
Journal:  Invest Radiol       Date:  2005-12       Impact factor: 6.016

2.  [Nutritional status in patients with chronic obstructive pulmonary disease].

Authors:  J Musil; S Musilová; M Kvapil
Journal:  Vnitr Lek       Date:  1997-04

Review 3.  Nutrition and chronic lung disease.

Authors:  D O Wilson; R M Rogers; R M Hoffman
Journal:  Am Rev Respir Dis       Date:  1985-12

4.  [The nutritional status and respiratory function of patients diagnosed with COPD].

Authors:  I Gil Canalda; C Gimeno Uribes; A I Cos Blanco; P Weisz Griedman; F García Ri; I García Talavera; C Gómez Candela
Journal:  Nutr Hosp       Date:  1995 Mar-Apr       Impact factor: 1.057

5.  Anthropometric and pulmonary function test profiles of outpatients with stable chronic obstructive pulmonary disease.

Authors:  Hamid Sahebjami; Jesse T Doers; Marta L Render; Terry L Bond
Journal:  Am J Med       Date:  1993-05       Impact factor: 4.965

6.  Clinical semi-starvation: depression of hypoxic ventilatory response.

Authors:  R C Doekel; C W Zwillich; C H Scoggin; M Kryger; J V Weil
Journal:  N Engl J Med       Date:  1976-08-12       Impact factor: 91.245

Review 7.  Role of conventional chest radiography in diagnosis and exclusion of emphysema.

Authors:  P C Pratt
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

8.  The nutritional status of patients with chronic obstructive pulmonary disease.

Authors:  A M Hunter; M A Carey; H W Larsh
Journal:  Am Rev Respir Dis       Date:  1981-10

Review 9.  Proteins used in nutritional assessment.

Authors:  A M Spiekerman
Journal:  Clin Lab Med       Date:  1993-06       Impact factor: 1.935

10.  Value of chest radiography in phenotyping chronic obstructive pulmonary disease.

Authors:  M Miniati; S Monti; J Stolk; G Mirarchi; F Falaschi; R Rabinovich; C Canapini; J Roca; K F Rabe
Journal:  Eur Respir J       Date:  2007-12-05       Impact factor: 16.671

View more
  5 in total

1.  Body composition in patients with stable chronic obstructive pulmonary disease: comparison with malnutrition in healthy smokers.

Authors:  Ayse Baccioglu; Banu Eris Gulbay; Turan Acıcan
Journal:  Eurasian J Med       Date:  2014-08-26

2.  Evaluation of plasma leptin, tumor necrosis factor-α, and prealbumin as prognostic biomarkers during clinical recovery from acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Anant Mohan; Sneh Arora; Arvind Uniyal; Rosemary Poulose; Kalpana Luthra; R M Pandey; Randeep Guleria
Journal:  Lung India       Date:  2017 Jan-Feb

3.  Serum inflammatory markers and nutritional status in patients with stable chronic obstructive pulmonary disease.

Authors:  Sneh Arora; Karan Madan; Anant Mohan; Mani Kalaivani; Randeep Guleria
Journal:  Lung India       Date:  2019 Sep-Oct

4.  Relationship between household air pollution from biomass smoke exposure, and pulmonary dysfunction, oxidant-antioxidant imbalance and systemic inflammation in rural women and children in Nigeria.

Authors:  Oluwafemi Oluwole; Ganiyu Olatunbosun Arinola; Godson Rowland Ana; Tess Wiskel; Dezheng Huo; Olufunmilayo Ibironke Olopade; Christopher Olusola Olopade
Journal:  Glob J Health Sci       Date:  2013-03-18

5.  Serum prealbumin as an effective prognostic indicator for determining clinical status and prognosis in patients with hemorrhagic stroke.

Authors:  Shen-Qi Zhang; Bin Peng; Creed M Stary; Zhi-Hong Jian; Xiao-Xing Xiong; Qian-Xue Chen
Journal:  Neural Regen Res       Date:  2017-07       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.